Topiramate
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
43063-729 -
Package NDC
43063-729-07 -
Package NDC
43063-729-21 -
Package NDC
43063-729-28 -
Package NDC
43063-729-30 -
Package NDC
43063-729-60 -
Application number
ANDA076343 -
SPL ID
60061fab-01bb-3c7f-e063-6394a90a4364 -
SPL set ID
9e516204-8f39-43c9-9f7e-d9777586f321 -
UNII
0H73WJJ391 -
RxCUI
199889
What the source publishes
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Active ingredients
- Topiramate
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Topiramate",
"splId": "60061fab-01bb-3c7f-e063-6394a90a4364",
"labels": [
{
"setId": "9e516204-8f39-43c9-9f7e-d9777586f321",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9e516204-8f39-43c9-9f7e-d9777586f321",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9e516204-8f39-43c9-9f7e-d9777586f321"
}
],
"routes": [
"ORAL"
],
"labeler": "PD-Rx Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "7 TABLET in 1 BOTTLE, PLASTIC (43063-729-07)",
"package_ndc": "43063-729-07",
"identifierStatus": "well-formed",
"marketing_start_date": "20180307"
},
{
"sample": false,
"description": "21 TABLET in 1 BOTTLE, PLASTIC (43063-729-21)",
"package_ndc": "43063-729-21",
"identifierStatus": "well-formed",
"marketing_start_date": "20170131"
},
{
"sample": false,
"description": "28 TABLET in 1 BOTTLE, PLASTIC (43063-729-28)",
"package_ndc": "43063-729-28",
"identifierStatus": "well-formed",
"marketing_start_date": "20161228"
},
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE, PLASTIC (43063-729-30)",
"package_ndc": "43063-729-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20171231"
},
{
"sample": false,
"description": "60 TABLET in 1 BOTTLE, PLASTIC (43063-729-60)",
"package_ndc": "43063-729-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20161129"
}
],
"productId": "43063-729_60061fab-01bb-3c7f-e063-6394a90a4364",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "43063-729",
"deaSchedule": null,
"genericName": "Topiramate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TOPIRAMATE",
"strength": "100 mg/1"
}
],
"applicationNumber": "ANDA076343",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20140612",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000008486",
"N0000185506",
"N0000182140"
],
"upc": [
"0343063729304"
],
"unii": [
"0H73WJJ391"
],
"rxcui": [
"199889"
],
"spl_set_id": [
"9e516204-8f39-43c9-9f7e-d9777586f321"
],
"pharm_class_pe": [
"Decreased Central Nervous System Disorganized Electrical Activity [PE]"
],
"pharm_class_moa": [
"Cytochrome P450 3A4 Inducers [MoA]",
"Cytochrome P450 2C19 Inhibitors [MoA]"
],
"manufacturer_name": [
"PD-Rx Pharmaceuticals, Inc."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:43063-729_60061fab-01bb-3c7f-e063-6394a90a4364"